CROWLEY Richard 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Nov 6, 2012
Insider Transaction Report
Form 4
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
- Sale
Common Stock, $.01 par value per share
2012-10-31$1.45/sh−2,010$2,915→ 339,290 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on April 30, 2011.